Dhanvantri Jeevan Rekha sets book closure for Sept 29 AGM

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Book closure runs from September 23 to September 29, 2026
  • Shareholders on record by September 22, 2026, can vote
  • 33rd AGM scheduled for September 29, 2026, via video conference
  • E-voting window opens on September 26 and closes on September 28
powered bylight_fuzz_icon
49383324

*this image is generated using AI for illustrative purposes only.

Dhanvantri Jeevan Rekha has fixed the book closure period for its 33rd Annual General Meeting. The register of members and share transfer books will remain closed from September 23, 2026, to September 29, 2026. This ensures only shareholders on record before the closure can vote at the meeting scheduled for Tuesday, September 29, 2026.

The Board of Directors approved these dates during a meeting held on August 27, 2026. The company will conduct the AGM through video conferencing or other audio-video means, in compliance with the Companies Act, 2013 and SEBI regulations.

Key Agenda Items

The Board considered and approved the following matters:

  • Convening of the 33rd AGM on Tuesday, September 29, 2026, at 3:00 pm.
  • Approval of the Board Report for the financial year ending March 31, 2026.
  • Appointment of Mr. Sarat Jain, a practicing company secretary based in Meerut, as the scrutinizer for the meeting.

Book Closure and E-Voting Details

Shareholders must be on record by September 22, 2026, to participate in the AGM. The cut-off date for ascertaining shareholders entitled to cast votes electronically is also September 22, 2026.

E-voting facilities will be available during the following period:

Event Date/Time
Commencement of E-voting Friday, September 26, 2026, at 9:00 am
End of E-voting Sunday, September 28, 2026, at 5:00 pm
Cut-off date for E-voting Tuesday, September 22, 2026

The Board meeting commenced at 3:00 pm and concluded at 5:30 pm on August 27, 2026.

Historical Stock Returns for Dhanvantri Jeevan Rekha

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%+9.32%0.0%+26.19%0.0%

What specific financial performance metrics or strategic initiatives are expected to be highlighted in the Board Report for the fiscal year ending March 31, 2026?

How might the transition to a fully virtual AGM format impact shareholder engagement levels and voting participation rates compared to previous years?

Are there any proposed dividend payouts or capital allocation plans likely to be discussed during the AGM that could influence investor sentiment?

Dhanvantri Jeevan Rekha
View Company Insights
View All News
like17
dislike

Dhanvantri Jeevan Rekha schedules board meeting for August 27

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Dhanvantri Jeevan Rekha Ltd will hold a board meeting on August 27, 2026, to discuss the AGM for FY26. The notice was filed with BSE under SEBI Listing Regulations. No financial results were disclosed in this procedural filing.

powered bylight_fuzz_icon
48684344

*this image is generated using AI for illustrative purposes only.

Dhanvantri Jeevan Rekha Ltd has scheduled a meeting of its Board of Directors for August 27, 2026. The primary purpose of the gathering is to consider the proposal for calling the company's Annual General Meeting (AGM) for the financial year ending 2026.

The board meeting is set to begin at 3:00 pm. The intimation was issued pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Ritika Bhandari, Company Secretary and Compliance Officer, signed the disclosure on August 19, 2026, from Meerut. The filing serves as formal notification to the Listing Department of BSE Limited.

The company operates Dhanvantri Hospital, a unit based in Meerut, Uttar Pradesh. The hospital holds NABH Pre Accredited status and is ISO 9001:2015 certified.

Historical Stock Returns for Dhanvantri Jeevan Rekha

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%+9.32%0.0%+26.19%0.0%

Will the upcoming AGM agenda include any proposals for dividend distribution or capital restructuring for FY2026?

How might the company's NABH Pre Accredited status influence its valuation or expansion plans in the competitive healthcare sector?

Are there any expected changes in the Board of Directors' composition or key management roles to be discussed at the August meeting?

Dhanvantri Jeevan Rekha
View Company Insights
View All News
like20
dislike

More News on Dhanvantri Jeevan Rekha

1 Year Returns:+26.19%